First Horizon Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.14K | Sell |
281
-134
| -32% | -$4.36K | ﹤0.01% | 1705 |
|
|
2025
Q1 | $15.7K | Buy |
415
+268
| +182% | +$10.1K | ﹤0.01% | 1430 |
|
|
2024
Q4 | $12K | Sell |
147
-410
| -74% | -$33.6K | ﹤0.01% | 1520 |
|
|
2024
Q3 | $63.6K | Sell |
557
-85
| -13% | -$9.71K | ﹤0.01% | 880 |
|
|
2024
Q2 | $48.5K | Sell |
642
-100
| -13% | -$7.55K | ﹤0.01% | 934 |
|
|
2024
Q1 | $50.7K | Sell |
742
-65
| -8% | -$4.44K | ﹤0.01% | 936 |
|
|
2023
Q4 | $50.7K | Hold |
807
| – | – | ﹤0.01% | 935 |
|
|
2023
Q3 | $41.1K | Buy |
807
+45
| +6% | +$2.29K | ﹤0.01% | 932 |
|
|
2023
Q2 | $38.1K | Buy |
762
+727
| +2,077% | +$36.3K | ﹤0.01% | 1007 |
|
|
2023
Q1 | $1.31K | Hold |
35
| – | – | ﹤0.01% | 2199 |
|
|
2022
Q4 | $1.68K | Buy |
+35
| New | +$1.68K | ﹤0.01% | 2108 |
|